Judi Health redefines health benefit management with a $400 million funding boost, enhancing transparency and efficiency for employers and health plans.
Investigators have identified the lowest dose of the immunosuppressive ATG needed to preserve beta cells in newly diagnosed children with Type 1 diabetes with the lowest side effects.
Yael Bensoussan, M.D., director of the University of South Florida Health Voice Center, discusses menopause-related voice ...
A groundbreaking NLP algorithm accurately identifies precancerous gastric and esophageal conditions from EHRs, enhancing early detection and personalized patient care.
Carbapenemase-producing Enterobacterales (CRE) surge in the U.S., with New Delhi metallo-β-lactamase (NDM) becoming a major public health threat.
The complete response letter was issued by the FDA during a routine inspection of a third-party fill-finish facility, not because of an issue with apitegromab.
Increasing the cholesterol-lowering protein ApoM in mice improved retinal health and may be the key to slowing age-related ...
An expert discusses how payers face multiple access challenges including high treatment costs exceeding $100,000 per patient, coverage restrictions through prior authorization and operational barriers ...
Employers adapt healthcare strategies amid rising costs, focusing on specialty drugs and chronic conditions to enhance ...
Data quality issues and increased rates of claim denials provide opportunities for artificial intelligence to make ...
Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback